Grantham, Mayo, Van Otterloo & Co (GMO)
NXGN

Grantham, Mayo, Van Otterloo & Co (GMO)’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-49,600
Closed -$878K – 792
2022
Q3 		$878K Sell
49,600
-62,400
-56% -$1.08M 0.01% 512
2022
Q2 		$1.95M Buy
112,000
+19,100
+21% +$364K 0.01% 440
2022
Q1 		$1.94M Buy
92,900
+47,700
+106% +$914K 0.01% 453
2021
Q4 		$804K Buy
+45,200
New +$726K ﹤0.01% 560
2021
Q1 		– Sell
-66,100
Closed -$1.21M – 965
2020
Q4 		$1.21M Sell
66,100
-99,400
-60% -$1.58M 0.01% 539
2020
Q3 		$2.11M Buy
165,500
+50,200
+44% +$641K 0.02% 397
2020
Q2 		$1.27M Buy
115,300
+89,400
+345% +$926K 0.01% 494
2020
Q1 		$270K Buy
+25,900
New +$334K ﹤0.01% 672
2019
Q1 		– Sell
-16,100
Closed -$244K – 755
2018
Q4 		$244K Sell
16,100
-3,800
-19% -$65.2K ﹤0.01% 497
2018
Q3 		$400K Hold
19,900
– – ﹤0.01% 458
2018
Q2 		$388K Hold
19,900
– – ﹤0.01% 488
2018
Q1 		$272K Hold
19,900
– – ﹤0.01% 527
2017
Q4 		$270K Sell
19,900
-3,200
-14% -$46K ﹤0.01% 532
2017
Q3 		$363K Buy
23,100
+1,900
+9% +$30.7K ﹤0.01% 447
2017
Q2 		$365K Buy
21,200
+2,400
+13% +$36.5K ﹤0.01% 440
2017
Q1 		$287K Buy
+18,800
New +$277K ﹤0.01% 440
2016
Q3 		– Sell
-29,200
Closed -$348K – 600
2016
Q2 		$348K Buy
+29,200
New +$393K ﹤0.01% 508

Other funds holding NXGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NXGN Position: Q4 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2022, closing a stake of 49,600 shares — an estimated $878K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NXGN in Q2 2016 and held it in 17 quarters. The position peaked at $2.11M in Q3 2020. 212 funds tracked by Wall St. Rank hold NXGN as of Q4 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 49,600 NextGen Healthcare, Inc. Common Stock shares in Q4 2022, an estimated $878K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2016 and held it in 17 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s NextGen Healthcare, Inc. Common Stock position peaked at $2.11M in Q3 2020.
  • 212 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2022, filed 13 Feb 2023.